{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:10:38Z","timestamp":1760109038289,"version":"build-2065373602"},"reference-count":145,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.cjca.2015.07.735","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T17:56:28Z","timestamp":1440179788000},"page":"1338-1350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Genetic Challenges and Opportunities in Advanced Heart Failure"],"prefix":"10.1016","volume":"31","author":[{"given":"Fady","family":"Hannah-Shmouni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara B.","family":"Seidelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Sirrs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arya","family":"Mani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2015.07.735_bib1","first-page":"e6","article-title":"Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCOUTCOMES.110.957225","article-title":"Lifetime costs of medical care after heart failure diagnosis","volume":"4","author":"Dunlay","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2015.07.735_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2015.07.735_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"suppl","key":"10.1016\/j.cjca.2015.07.735_bib5","first-page":"P9","article-title":"Clinical epidemiology of heart failure: public and private health burden","volume":"19","author":"McMurray","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2015.07.735_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0300-8932(02)76691-8","article-title":"Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy","volume":"55","author":"Monserrat","year":"2002","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCHEARTFAILURE.114.001435","article-title":"Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant","volume":"7","author":"Rowin","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2015.07.735_bib8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib10","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib11","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0735-1097(95)00390-8","article-title":"Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients","volume":"26","author":"Klues","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/CIRCEP.111.962035","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"5","author":"Basso","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib13","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/01.CIR.97.20.2049","article-title":"Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21","volume":"97","author":"Coonar","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","article-title":"Restrictive cardiomyopathy","volume":"336","author":"Kushwaha","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.hfc.2009.11.005","article-title":"Genetics of restrictive cardiomyopathy","volume":"6","author":"Sen-Chowdhry","year":"2010","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cjca.2015.07.735_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI62862","article-title":"Genetic mutations and mechanisms in dilated cardiomyopathy","volume":"123","author":"McNally","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2015.07.735_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/HCO.0b013e32832a11e7","article-title":"Left ventricular noncompaction","volume":"24","author":"Pantazis","year":"2009","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehm481","article-title":"Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?","volume":"29","author":"Kohli","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2015.07.735_bib19","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jacc.2014.08.030","article-title":"Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases?","volume":"64","author":"Arbustini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10545-009-1202-0","article-title":"Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD)","volume":"32","author":"Lang","year":"2009","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.cjca.2015.07.735_bib21","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/B978-0-444-59565-2.00035-6","article-title":"Disorders of fatty acid oxidation","volume":"113","author":"Tein","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.cjca.2015.07.735_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10545-010-9090-x","article-title":"Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening","volume":"33","author":"Spiekerkoetter","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.cjca.2015.07.735_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","article-title":"Prevalence of mitochondrial DNA disease in adults","volume":"63","author":"Schaefer","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cjca.2015.07.735_bib24","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1012478","article-title":"Monogenic mitochondrial disorders","volume":"366","author":"Koopman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib25","doi-asserted-by":"crossref","unstructured":"De Castro M, Johnston J, Biesecker L. Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data [e-pub ahead of print]. Genet Med http:\/\/dx.doi.org\/10.1038\/gim.2015.9, accessed March 5, 2015.","DOI":"10.1038\/gim.2015.9"},{"key":"10.1016\/j.cjca.2015.07.735_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-med-090910-085119","article-title":"The Fabry cardiomyopathy: models for the cardiologist","volume":"62","author":"Weidemann","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","article-title":"Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment","volume":"4","author":"Niemann","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2015.07.735_bib30","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM198911163212005","article-title":"Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1","volume":"321","author":"Jarcho","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/GIM.0b013e31819d30f2","article-title":"HFE-associated hereditary hemochromatosis","volume":"11","author":"Alexander","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib33","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2015.07.735_bib34","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/ncpcardio1350","article-title":"Molecular genetics of arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"5","author":"Milting","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCULATIONAHA.109.914838","article-title":"Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies\/channelopathies in clinical practice","volume":"123","author":"Tester","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/hc0402.102990","article-title":"Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly","volume":"105","author":"Niimura","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/jhg.2012.72","article-title":"Danon disease: focusing on heart","volume":"57","author":"Cheng","year":"2012","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.cjca.2015.07.735_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/hrt.2010.200188","article-title":"Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study","volume":"97","author":"Hagege","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2015.07.735_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10545-013-9659-2","article-title":"Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS)","volume":"37","author":"Palecek","year":"2014","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.cjca.2015.07.735_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/eurjhf\/hfq073","article-title":"Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women","volume":"12","author":"Havndrup","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2015.07.735_bib41","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.ijcard.2012.06.069","article-title":"Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy","volume":"167","author":"Terryn","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1212\/WNL.56.4.431","article-title":"Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment","volume":"56","author":"Hund","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cjca.2015.07.735_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.28.2.73","article-title":"Inherited amyloidosis","volume":"28","author":"Benson","year":"1991","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cjca.2015.07.735_bib44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib46","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.43.6.1200","article-title":"Clinical features associated with the A-->G transition at nucleotide 8344 of mtDNA (\u201cMERRF mutation\u201d)","volume":"43","author":"Silvestri","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.cjca.2015.07.735_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jpeds.2006.12.047","article-title":"Cardiac manifestations in oxidative phosphorylation disorders of childhood","volume":"150","author":"Yaplito-Lee","year":"2007","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cjca.2015.07.735_bib48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2169\/internalmedicine.53.1386","article-title":"Refractory high output heart failure in a patient with primary mitochondrial respiratory chain disease","volume":"53","author":"Nakagawa","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S031716710001115X","article-title":"Multisystem disorder in late-onset chronic progressive external ophthalmoplegia","volume":"38","author":"Pfeffer","year":"2011","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.cjca.2015.07.735_bib50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/0003-4819-120-3-199402010-00008","article-title":"Glycogen storage disease in adults","volume":"120","author":"Talente","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nrcardio.2013.108","article-title":"Genetic testing for inherited cardiac disease","volume":"10","author":"Wilde","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib52","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/eurheartj\/ehq136","article-title":"Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy","volume":"31","author":"Melacini","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2015.07.735_bib53","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmoldx.2012.09.002","article-title":"Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era","volume":"15","author":"Teekakirikul","year":"2013","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.cjca.2015.07.735_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cjca.2015.07.735_bib56","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0002-9149(97)89194-1","article-title":"The varying evolution of Friedreich\u2019s ataxia cardiomyopathy","volume":"77","author":"Casazza","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib57","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.mayocp.2014.01.025","article-title":"Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy","volume":"89","author":"Bos","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2015.07.735_bib58","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0025-6196(11)61527-9","article-title":"Yield of genetic testing in hypertrophic cardiomyopathy","volume":"80","author":"Van Driest","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2015.07.735_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/humu.20862","article-title":"Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives","volume":"30","author":"Andersen","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cjca.2015.07.735_bib60","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199703133361107","article-title":"The management of hypertrophic cardiomyopathy","volume":"336","author":"Spirito","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib61","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1365-2362.2010.02349.x","article-title":"Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study","volume":"40","author":"Nagueh","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cjca.2015.07.735_bib62","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCHEARTFAILURE.109.922872","article-title":"Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy","volume":"3","author":"Maron","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2015.07.735_bib63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCEP.109.919530","article-title":"Lack of uniform progression of endocardial scar in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy and ventricular tachycardia","volume":"3","author":"Riley","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCEP.111.968677","article-title":"Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"5","author":"Philips","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib65","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.106.624502","article-title":"Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice","volume":"114","author":"Kirchhof","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib66","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib67","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.0000128363.85581.E1","article-title":"Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases","volume":"109","author":"Maron","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib68","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2009.11.020","article-title":"Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy","volume":"55","author":"Xu","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jacc.2011.09.051","article-title":"Cardiac transplantation in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"59","author":"Tedford","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib70","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.healun.2012.09.018","article-title":"Outcomes of adults with restrictive cardiomyopathy after heart transplantation","volume":"31","author":"DePasquale","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2015.07.735_bib71","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib72","doi-asserted-by":"crossref","first-page":"CR537","DOI":"10.12659\/MSM.881977","article-title":"Predictors of cardiac hepatopathy in patients with right heart failure","volume":"17","author":"Megalla","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.cjca.2015.07.735_bib73","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib74","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCHEARTFAILURE.110.959288","article-title":"Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy","volume":"4","author":"Topilsky","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2015.07.735_bib75","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCHEARTFAILURE.113.000125","article-title":"Predictors of disease progression in pediatric dilated cardiomyopathy","volume":"6","author":"Molina","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2015.07.735_bib76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-143-2-200507190-00009","article-title":"Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease","volume":"143","author":"Mahon","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib77","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/TP.0b013e3181c35255","article-title":"Heart transplantation in women with dilated cardiomyopathy","volume":"89","author":"Regitz-Zagrosek","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2015.07.735_bib78","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIRCULATIONAHA.112.095059","article-title":"Left ventricular noncompaction cardiomyopathy: an overdiagnosed disease","volume":"126","author":"Niemann","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib79","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ymgme.2012.03.011","article-title":"30-year follow-up of a patient with classic citrullinemia","volume":"106","author":"Brunetti-Pierri","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cjca.2015.07.735_bib80","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1503\/cmaj.110518","article-title":"Recurrent exercise-induced rhabdomyolysis","volume":"184","author":"Hannah-Shmouni","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2015.07.735_bib81","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib82","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/CND.0000000000000012","article-title":"Intermittent rhabdomyolysis with adult onset associated with a mutation in the ACADVL gene","volume":"15","author":"Antunes","year":"2013","journal-title":"J\u00a0Clin Neuromusc Dis"},{"key":"10.1016\/j.cjca.2015.07.735_bib83","doi-asserted-by":"crossref","first-page":"H326","DOI":"10.1152\/ajpheart.00931.2012","article-title":"Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance","volume":"306","author":"Xiong","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib84","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2011.09.030","article-title":"Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation","volume":"105","author":"Behrend","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cjca.2015.07.735_bib85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10545-013-9628-9","article-title":"Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study from 187 patients. Complementary data","volume":"37","author":"Baruteau","year":"2014","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.cjca.2015.07.735_bib86","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0002-9440(10)65738-0","article-title":"Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy","volume":"153","author":"Arbustini","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cjca.2015.07.735_bib87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/B:BOLI.0000031098.41409.55","article-title":"Mitochondrial disorders: prevalence, myths and advances","volume":"27","author":"Thorburn","year":"2004","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.cjca.2015.07.735_bib88","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1566524024605815","article-title":"The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies","volume":"2","author":"Moses","year":"2002","journal-title":"Curr Mol Med"},{"issue":"suppl 3","key":"10.1016\/j.cjca.2015.07.735_bib90","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1007\/s10545-010-9096-4","article-title":"Glycogen storage disease type III in the Irish population","volume":"33","author":"Crushell","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.cjca.2015.07.735_bib91","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","article-title":"Spontaneous \u201csecond wind\u201d and glucose-induced second \u201csecond wind\u201d in McArdle disease: oxidative mechanisms","volume":"59","author":"Haller","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cjca.2015.07.735_bib92","first-page":"205","article-title":"The Mount Sinai Hospital clinicalpathological conference: a 45-year-old man with Pompe\u2019s disease and dilated cardiomyopathy","volume":"68","author":"Ben-Ami","year":"2001","journal-title":"Mount Sinai J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib93","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-7-35","article-title":"A\u00a0cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations","volume":"7","author":"Herzog","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cjca.2015.07.735_bib94","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM200106143442403","article-title":"Identification of a gene responsible for familial Wolff-Parkinson-White syndrome","volume":"344","author":"Gollob","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib95","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s00246-009-9521-3","article-title":"Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation","volume":"30","author":"Kelly","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib96","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/CIRCULATIONAHA.107.726752","article-title":"Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations","volume":"117","author":"Wolf","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib97","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib98","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2015.07.735_bib99","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population","volume":"2","author":"Lin","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2015.07.735_bib100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvq308","article-title":"Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart","volume":"89","author":"Creemers","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2015.07.735_bib101","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCGENETICS.109.895763","article-title":"Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium","volume":"3","author":"Smith","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2015.07.735_bib102","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1073\/pnas.1017494108","article-title":"Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation","volume":"108","author":"Cappola","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2015.07.735_bib103","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrg2983","article-title":"Heart failure: advances through genomics","volume":"12","author":"Creemers","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cjca.2015.07.735_bib104","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","author":"International Human Genome Sequencing Consortium","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2015.07.735_bib105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamainternmed.2013.12048","article-title":"The promise and challenges of next-generation genome sequencing for clinical care","volume":"174","author":"Johansen Taber","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib106","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrg3031","article-title":"Exome sequencing as a tool for Mendelian disease gene discovery","volume":"12","author":"Bamshad","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cjca.2015.07.735_bib107","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cardfail.2012.01.002","article-title":"Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something new","volume":"18","author":"Talameh","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2015.07.735_bib108","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00008571-200208000-00007","article-title":"Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment","volume":"12","author":"Rau","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cjca.2015.07.735_bib109","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clpt.2004.08.020","article-title":"Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension","volume":"76","author":"Zineh","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjca.2015.07.735_bib110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2217\/pgs.11.20","article-title":"Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics","volume":"12","author":"Sehrt","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cjca.2015.07.735_bib111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/clpt.2008.172","article-title":"Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users","volume":"85","author":"Bijl","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjca.2015.07.735_bib112","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","article-title":"Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity","volume":"73","author":"Hasking","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib113","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9149(78)90162-5","article-title":"Plasma norepinephrine in congestive heart failure","volume":"41","author":"Thomas","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib114","first-page":"20","article-title":"The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial","volume":"2","author":"Eichhorn","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib115","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib116","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2046-4053-2-7","article-title":"Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design","volume":"2","author":"Kotecha","year":"2013","journal-title":"Syst Rev"},{"key":"10.1016\/j.cjca.2015.07.735_bib117","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2015.07.735_bib118","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1073\/pnas.0509937103","article-title":"A\u00a0polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure","volume":"103","author":"Liggett","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2015.07.735_bib119","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/nm930","article-title":"Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure","volume":"9","author":"Mialet Perez","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib120","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1053\/euhj.1999.1994","article-title":"A\u00a0novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure","volume":"21","author":"Borjesson","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2015.07.735_bib121","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clpt.2005.06.004","article-title":"Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy","volume":"78","author":"Magnusson","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjca.2015.07.735_bib122","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.294.12.1526","article-title":"Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome","volume":"294","author":"Lanfear","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2015.07.735_bib123","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00008571-200307000-00002","article-title":"Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure","volume":"13","author":"Kaye","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cjca.2015.07.735_bib124","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjcard.2006.08.020","article-title":"Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure","volume":"99","author":"Shin","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/FPC.0b013e3280105245","article-title":"Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure","volume":"17","author":"Lobmeyer","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.cjca.2015.07.735_bib126","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/FPC.0b013e3282ef7354","article-title":"Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol","volume":"17","author":"Chen","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.cjca.2015.07.735_bib127","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/HYPERTENSIONAHA.110.158667","article-title":"Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals","volume":"57","author":"Johnson","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2015.07.735_bib128","first-page":"1429","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group","volume":"316","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib130","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2015.07.735_bib131","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.ehj.2004.08.026","article-title":"Angiotensin converting enzyme insertion\/deletion polymorphism and the risk of heart failure in hypertensive subjects","volume":"25","author":"Schut","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2015.07.735_bib132","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2310\/JIM.0b013e31818e8028","article-title":"ACE insertion\/deletion, but not -240A>T polymorphism, modulates the severity in heart failure","volume":"56","author":"Fatini","year":"2008","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib133","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1071-9164(96)80009-1","article-title":"Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure","volume":"2","author":"Struthers","year":"1996","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2015.07.735_bib134","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0735-1097(96)00098-8","article-title":"The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure","volume":"28","author":"Andersson","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib135","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.CIR.103.2.226","article-title":"Left ventricular hypertrophy with exercise and ACE gene insertion\/deletion polymorphism: a randomized controlled trial with losartan","volume":"103","author":"Myerson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.07.735_bib136","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0735-1097(01)01237-2","article-title":"Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype","volume":"37","author":"Cicoira","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib137","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.jacc.2004.08.048","article-title":"Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure","volume":"44","author":"McNamara","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.07.735_bib138","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/jama.287.13.1680","article-title":"Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension","volume":"287","author":"Psaty","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2015.07.735_bib139","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00228-003-0567-5","article-title":"Digoxin pharmacokinetics and MDR1 genetic polymorphisms","volume":"58","author":"Verstuyft","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2015.07.735_bib140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jash.2014.04.011","article-title":"Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans","volume":"8","author":"Laffer","year":"2014","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.cjca.2015.07.735_bib141","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/clpt.2010.279","article-title":"CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjca.2015.07.735_bib142","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/mt.2008.61","article-title":"Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats","volume":"16","author":"Niwano","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2015.07.735_bib143","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1161\/hh1101.092004","article-title":"Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure","volume":"88","author":"del Monte","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2015.07.735_bib144","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Car\u00e8","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2015.07.735_bib145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nature13073","article-title":"Inhibition of miR-25 improves cardiac contractility in the failing heart","volume":"508","author":"Wahlquist","year":"2014","journal-title":"Nature"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X15013161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X15013161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:39:03Z","timestamp":1760107143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X15013161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":145,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0828282X15013161"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2015.07.735","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Genetic Challenges and Opportunities in Advanced Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2015.07.735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}